• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Circassia Pharmaceuticals Gets U.S. Lung Drug Rights From AstraZeneca

    Circassia Pharmaceuticals Gets U.S. Lung Drug Rights From AstraZeneca

  2. AstraZeneca Hyperkalaemia Drug Application Under Review

    AstraZeneca Hyperkalaemia Drug Application Under Review

  3. AstraZeneca ’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines

    AstraZeneca ’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines

  4. Astrazeneca , Sanofi Team Up To Make Breathing-Illness Vaccine

    Astrazeneca , Sanofi Team Up To Make Breathing-Illness Vaccine

  5. AstraZeneca Gives Rejected Drugs a Second Life

    AstraZeneca Gives Rejected Drugs a Second Life

  6. Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

    Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

  7. Hospital Acquired Infection (HAI) Control Markets 2010-2021 - Research and Markets

    Hospital Acquired Infection (HAI) Control Markets 2010-2021 - Research and Markets

  8. X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration

    X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration

  9. Infertility Services Market in US to Grow at a CAGR of 4.65% by 2021 - Driven by the Rising Success Rate of Infertility Treatments - Research and Markets

    Infertility Services Market in US to Grow at a CAGR of 4.65% by 2021 - Driven by the Rising Success Rate of Infertility Treatments - Research and Markets

  10. FiscalNote Expands Executive Team, Names Longtime LexisNexis Exec Martin Kilmer As Chief Operating Officer

    FiscalNote Expands Executive Team, Names Longtime LexisNexis Exec Martin Kilmer As Chief Operating Officer

12345

©2017 Morningstar Advisor. All right reserved.